ArticleJournal of hematology2025

Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis.

Yudai Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.